BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23494279)

  • 1. [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].
    Ott MM; Horn H; Rosenwald A; Ott G
    Pathologe; 2013 May; 34(3):225-32. PubMed ID: 23494279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.
    Ott G
    Br J Haematol; 2017 Sep; 178(6):871-887. PubMed ID: 28748558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Grayzone lymphoma. Clinical relevance].
    Hartmann S; Hansmann ML
    Pathologe; 2010 Feb; 31(1):42-9. PubMed ID: 20013122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J
    Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
    Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
    Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
    Rentas Torres Y; Rodríguez-López JL; Valentin M; Silva H
    Bol Asoc Med P R; 2015; 107(3):98-101. PubMed ID: 26742206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive B-cell lymphomas: how many categories do we need?
    Said JW
    Mod Pathol; 2013 Jan; 26 Suppl 1(0 1):S42-56. PubMed ID: 23154748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
    Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M
    Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Stejskalová E; Kabícková E
    Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
    Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Large B-cell lymphomas: variants and entities].
    Anagnostopoulos I; Stein H
    Pathologe; 2000 Mar; 21(2):178-89. PubMed ID: 10840822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification and differential diagnosis of B-cell lymphomas].
    Anagnostopoulos I
    Verh Dtsch Ges Pathol; 2003; 87():32-42. PubMed ID: 16888892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
    Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
    Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
    Grimm KE; O'Malley DP
    Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.